BU-NOT-SET

CONTACT US
Overcoming technical transfer challenges in virotherapy manufacturing
  • Biologics
virotherapy
Insight
Flexibility in gene therapy: Adapting to the unique gene therapy demands
  • Biologics
gene therapy
eBook
Webinar: An optimised Plasmid DNA platform
  • Biologics
Plasmid DNA
Webinar
The future of oral solid dose formulations
  • Drug substance
  • Industry trends
oral solid dose
Insight
Trends and challenges to impact the OSD space in 2024 and beyond
  • Industry trends
OSD
Insight
Shaping pharma's carbon-reduced future
  • Sustainability
Sustainability
Insight
Focus on sustainability: Saving water in Bengaluru
  • Sustainability
Clouds
Insight
Safe handling of highly potent active pharmaceutical ingredients
  • Drug product
  • Drug substance
Safe handling
Insight
Development and validation of ICP-OES for trace element estimation
  • Analytical chemistry
oral solid dose
White paper
Insight
  • Analytical chemistry
The QbD approach: Key advantages in clinical and commercial phases
Report
  • Sustainability
Sustainability report 2020
Poster
  • Drug substance
Recipharm and Oncopeptides: Successful collaboration in the development of melflufen, a peptidase-potentiated alkylating agent in clinical trials
Fact sheet
  • Analytical chemistry
Recipharm Analytical Solutions™
Fact sheet
  • Analytical chemistry
Impurity identification
Fact sheet
  • Analytical chemistry
Stability studies
Fact sheet
  • Analytical chemistry
Extractables & leachables testing
Insight
  • Industry trends
Pharmaceutical mergers and acquisitions: opportunities and drivers for CDMOs
Insight
  • Industry trends
Global expansion in the CDMO field